https://www.wsj.com/articles/bidens-alzheimers-lapse-drug-medicare-premiums-aduhelm-biogen-11664403263?mod=opinion_lead_pos2
President Biden on Tuesday claimed credit for a modest decline in Medicare premiums, but he forgot to mention the reason: His Administration is rationing a novel Alzheimer’s drug.
“This year, the American people won, and Big Pharma lost,” the President said in a speech in which he accused Republicans of seeking to gut entitlements and flogged Medicare drug price controls that Democrats are using to pay for $369 billion in new climate spending. But Democrats are the party slashing Medicare via cost rationing.
He continued: “This morning, we got more even good news about lowering costs. The Department of Health and Human Services announced that the premium for Part B will, in fact, decrease this [upcoming] year,” adding that “for years, that fee has gone up. Now, for the first time in more than a decade, it’s going to go down.”
Mr. Biden wants Americans to believe that drug price controls are reducing premiums. But here’s the deal: His Administration increased Part B premiums by 14.5% this year and blamed the increase on expected high demand for Biogen’s Alzheimer’s drug Aduhelm, which the Food and Drug Administration approved last summer.
